Neurotensin Receptor 1 Antagonist SR48692 Improves Response to Carboplatin by Enhancing Apoptosis and Inhibiting Drug Efflux in Ovarian Cancer
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-17-0861
Full Text
Open PDFAbstract
Available in full text
Date
August 8, 2017
Authors
Publisher
American Association for Cancer Research (AACR)